Table 3 Proportion of patients alive at 6 and 12 months after receiving I or O as initial treatment

From: Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis

 

Either I or O

First supply I

First supply O

Proportion alive at 6 months

0.67

0.65

0.69

Proportion alive at 12 months

0.42

0.40

0.44

  1. I, irinotecan; O, oxaliplatin.
Back to article page